Cargando…
Secretagogin is Related to Insulin Secretion but Unrelated to Gestational Diabetes Mellitus Status in Pregnancy
Secretagogin (SCGN) is a calcium binding protein related to insulin release in the pancreas. Although SCGN is not co-released with insulin, plasma concentrations have been found to be increased in type 2 diabetes mellitus patients. Until now, no study on SCGN levels in pregnancy or patients with ges...
Autores principales: | Deischinger, Carola, Harreiter, Jürgen, Leitner, Karoline, Bancher-Todesca, Dagmar, Baumgartner-Parzer, Sabina, Kautzky-Willer, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408624/ https://www.ncbi.nlm.nih.gov/pubmed/32708966 http://dx.doi.org/10.3390/jcm9072277 |
Ejemplares similares
-
SUN-639 Secretagogin Levels Are Unrelated to Gestational Diabetes Mellitus in a Cohort of Pregnant Women
por: Deischinger, Carola, et al.
Publicado: (2020) -
CTRP-1 levels are related to insulin resistance in pregnancy and gestational diabetes mellitus
por: Deischinger, Carola, et al.
Publicado: (2020) -
Gremlin-1 in pregnancy and postpartum: relation to the fatty liver index, markers of bone health, glucose metabolism and gestational diabetes mellitus status
por: Deischinger, Carola, et al.
Publicado: (2023) -
Glypican-4 in pregnancy and its relation to glucose metabolism, insulin resistance and gestational diabetes mellitus status
por: Deischinger, Carola, et al.
Publicado: (2021) -
The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus
por: Firneisz, Gábor, et al.
Publicado: (2018)